1. S281: PRIOR EXPOSURE TO IMMUNOSUPPRESSIVE AGENTS AND COMORBIDITIES ARE ASSOCIATED WITH WORSE OUTCOMES OF SARS-COV2 INFECTION IN PH-NEG CHRONIC MYELOPROLIFERATIVE NEOPLASMS: RESULTS OF EPICOVIDEHA SURVEY. (23rd June 2022) Authors: Marchetti, M.; Salmanton-García, J.; El-Ashwah, S.; Sacchi, M. V.; Marchesi, F.; Ráčil, Z.; Hanakova, M.; Zambrotta, G.; Verga, L.; Passamonti, F.; Itri, F.; Van Doesum, J.; Martìn-Pérez, S.; López-García, A.; Dávila-Valls, J.; Cordoba, R.; Abu-Zeinah, G.; Dragonetti, G.; Cattaneo, C.; Bonuomo, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA). (23rd June 2022) Authors: Infante, M. S.; Salmanton-García, J.; Fernandez-Cruz, A.; Marchesi, F.; RÁČIL, Z.; Hanakova, M.; Jaksic, O.; Weinbergerova, B.; Besson, C.; Duarte, R.; Itri, F.; VALKOVIĆ, T.; Busca, A.; Guidetti, A.; GLENTHØJ, A.; Collins, G.; Bonuomo, V.; Sili, U.; Seval, G.; Machado, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Issue 1 (30th December 2013) Authors: Blennow, O.; Ljungman, P.; Sparrelid, E.; Mattsson, J.; Remberger, M. Journal: Transplant infectious disease Issue: Volume 16:Issue 1(2014) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗